Christoph Neumayer

Prof. Christoph Neumayer

orcid

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
JKJohannes Klopf
Johannes Klopf
CBChristine Brostjan
Christine Brostjan
WEWolf Eilenberg
Wolf Eilenberg
CNChristoph Neumayer
Christoph Neumayer
Neutrophils are primary effector cells of innate immunity and fight infection by phagocytosis and degranulation. Activated neutrophils also release neutrophil extracellular traps (NETs) in response to a variety of stimuli. These NETs are net-like complexes composed of cell-free DNA, histones and neutrophil granule proteins. Besides the evolutionarily conserved mechanism to capture and eliminate pathogens, NETs are also associated with pathophysiological processes of various diseases. Here, we elucidate the mechanisms of NET formation and their different implications in disease. We focused on autoinflammatory and cardiovascular disorders as the leading cause of death. Neutrophil extracellular traps are not only present in various cardiovascular diseases but play an essential role in atherosclerotic plaque formation, arterial and venous thrombosis, as well as in the development and progression of abdominal aortic aneurysms. Furthermore, NETosis can be considered as a source of autoantigens and maintains an inflammatory milieu promoting autoimmune diseases. Indeed, there is further need for research into the balance between NET induction, inhibition, and degradation in order to pharmacologically target NETs and their compounds without impairing the patient’s immune defense. This review may be of interest to both basic scientists and clinicians to stimulate translational research and innovative clinical approaches.

2 January 2022 in Biomedicines
Verified
Journal Article
Open access
PDF file
VKVeronika Kessler
Veronika Kessler
JKJohannes Klopf
Johannes Klopf
WEWolf Eilenberg
Wolf Eilenberg
CNChristoph Neumayer
Christoph Neumayer
CBChristine Brostjan
Christine Brostjan
Despite declining incidence and mortality rates in many countries, the abdominal aortic aneurysm (AAA) continues to represent a life-threatening cardiovascular condition with an overall prevalence of about 2–3% in the industrialized world. While the risk of AAA development is considerably higher for men of advanced age with a history of smoking, screening programs serve to detect the often asymptomatic condition and prevent aortic rupture with an associated death rate of up to 80%. This review summarizes the current knowledge on identified risk factors, the multifactorial process of pathogenesis, as well as the latest advances in medical treatment and surgical repair to provide a perspective for AAA management.

16 September 2021 in Biomedicines
Verified
Journal Article
Open access
PDF file
JKJohannes Klopf
Johannes Klopf
CBChristine Brostjan
Christine Brostjan
CNChristoph Neumayer
Christoph Neumayer
WEWolf Eilenberg
Wolf Eilenberg
Neutrophils represent up to 70% of circulating leukocytes in healthy humans and combat infection mostly by phagocytosis, degranulation and NETosis. It has been reported that neutrophils are centrally involved in abdominal aortic aneurysm (AAA) pathogenesis. The natural course of AAA is growth and rupture, if left undiagnosed or untreated. The rupture of AAA has a very high mortality and is currently among the leading causes of death worldwide. The use of noninvasive cardiovascular imaging techniques for patient screening, surveillance and postoperative follow-up is well established and recommended by the current guidelines. Neutrophil-derived biomarkers may offer clinical value to the monitoring and prognosis of AAA patients, allowing for potential early therapeutic intervention. Numerous promising biomarkers have been studied. In this review, we discuss neutrophils and neutrophil-derived molecules as regulators and biomarkers of AAA, and our aim was to specifically highlight diagnostic and prognostic markers. Neutrophil-derived biomarkers may potentially, in the future, assist in determining AAA presence, predict size, expansion rate, rupture risk, and postoperative outcome once validated in highly warranted future prospective clinical studies.

1 June 2006 in Journal of Surgical Research
Verified
Journal Article
Closed access
CNChristoph Neumayer
Christoph Neumayer
AFAlexander Fügl
Alexander Fügl
JNJosef Nanobashvili
Josef Nanobashvili
RBRoland Blumer
Roland Blumer
APAndreas Punz
Andreas Punz
IHIhor Huk
Ihor Huk

11 April 2006 in British Journal of Surgery
Verified
Journal Article
Open access
PDF file
PPP Panhofer
P Panhofer
JZJ Zacherl
J Zacherl
RJR Jakesz
R Jakesz
GBG Bischof
G Bischof
CNChristoph Neumayer
Christoph Neumayer
The aim of the study was to assess two disease-specific quality of life (QoL) instruments after limited endoscopic thoracic sympathetic block (TS) at T4 for upper limb hyperhidrosis. Between 2001 and 2005, 112 patients underwent 223 TS procedures in a prospective study. Some 103 patients (92·0 per cent) had palmar, 87 (77·7 per cent) had axillary and 75 (67·0 per cent) had combined hyperhidrosis. QoL questionnaires devised by Keller et al. and Milanez de Campos et al. were employed before and after treatment. Mean(s.d.) follow-up was 21·9(10·1) months. A total of 106 patients (94·6 per cent) were evaluated. All patients with palmar hyperhidrosis were completely or almost dry after surgery. Side-effects of compensatory sweating and gustatory sweating were observed in 17·0 and 28·3 per cent of patients respectively. QoL improved after TS in 100 per cent (Keller) and 97·3 per cent (Milanez de Campos) of patients illustrated by ameliorated scores of 78·7 and 67·8 per cent, respectively (both P < 0·001). Both questionnaires showed that compensatory sweating resulted in reduced postoperative QoL (P = 0·011, Keller; P = 0·032, Milanez de Campos). Endoscopic sympathetic block at T4 leads to improved QoL. Both current questionnaires fulfilled validation criteria for disease-specific QoL instruments in upper limb hyperhidrosis.

1 July 2005 in Archives of Surgery
Verified
Journal Article
Closed access
PDF file
CNChristoph Neumayer
Christoph Neumayer
PPPeter Panhofer
Peter Panhofer
JZJohannes Zacherl
Johannes Zacherl
GBGeorg Bischof
Georg Bischof
Research from JAMA Surgery — Effect of Endoscopic Thoracic Sympathetic Block on Plantar Hyperhidrosis